Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Protein Science : a Publication of the Protein Society|August 2, 2016
Characterization of low affinity Fcγ receptor biotinylation under controlled reaction conditions by mass spectrometry and ligand binding analysisKarin P M Geuijen, David F Egging, Stefanie Bartels, et al.
Biotechnology Journal|July 22, 2017
Rapid Buffer and Ligand Screening for Affinity Chromatography by Multiplexed Surface Plasmon Resonance ImagingKarin P M Geuijen, Daniëlle E J W van Wijk-Basten, David F Egging, et al.
FEBS Open Bio|October 6, 2017
Rapid screening of IgG quality attributes - effects on Fc receptor bindingKarin P M Geuijen, Cindy Oppers-Tiemissen, David F Egging, et al.
Cell and Tissue Research|March 13, 2008
Analysis of obstetric complications and uterine connective tissue in tenascin-X-deficient humans and miceDavid F Egging, Ivonne van Vlijmen-Willems, Jiwon Choi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 17, 2017
Switching from branded to generic glatiramer acetate: 15-month GATE trial extension resultsKrzysztof Selmaj, Frederik Barkhof, Anna N Belova, et al.
Mabs|October 7, 2015
A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgAGerard Ja Rouwendal, Miranda M van der Lee, Saskia Meyer, et al.
Molecular Cancer Therapeutics|August 11, 2018
Unraveling the Interaction between Carboxylesterase 1c and the Antibody-Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout MiceRuud Ubink, Eef H C Dirksen, Myrthe Rouwette, et al.
Molecular Cancer Therapeutics|January 16, 2015
The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast CancersMiranda M C van der Lee, Patrick G Groothuis, Ruud Ubink, et al.
Molecular Pharmaceutics|January 31, 2015
Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody-Drug Conjugate SYD985Ronald C Elgersma, Ruud G E Coumans, Tijl Huijbregts, et al.
Pageof 1